Overview
Headspace Health merged Headspace and Ginger to create a comprehensive mental health super-app offering meditation, coaching, and on-demand therapy. Their enterprise and health plan products are used by over 100 million people worldwide.
Headspace Health is a mental health technology company headquartered in Santa Monica, California, formed through the merger of Headspace and Ginger to create one of the most comprehensive digital mental health platforms available today. The company offers a unified super-app that integrates guided meditation, mindfulness content, behavioral health coaching, and on-demand therapy and psychiatry services into a single, accessible experience. Their platform leverages data-driven personalization and digital therapeutics to match users with the appropriate level of care, ranging from self-guided tools to licensed clinicians. This layered care model is designed to meet users wherever they are on the mental health spectrum, reducing barriers to access and streamlining the path to professional support.
Headspace Health has established a significant market presence, with its enterprise and health plan products reaching over 100 million people worldwide through partnerships with employers and insurance providers. The merger of Headspace and Ginger brought together a consumer mindfulness brand with strong name recognition and a clinically validated coaching and therapy network, creating a differentiated competitive position in the crowded digital health landscape. The company has pursued a dual go-to-market strategy targeting both individual consumers and enterprise clients, securing contracts with major corporations and health plans seeking scalable mental health benefits solutions. Their public market presence through NASDAQ under the ticker MNMD reflects investor confidence in the long-term commercial viability of scalable mental health infrastructure.
Headspace Health represents a meaningful development for the broader neurotechnology and mental health tech industry by demonstrating that consumer wellness tools and clinical mental health services can be successfully integrated into a single scalable platform. Their approach validates the growing industry thesis that early-stage digital interventions, such as mindfulness and coaching, can serve as effective on-ramps to more structured clinical care, potentially reducing the burden on traditional healthcare systems. By combining behavioral data, clinical expertise, and technology at scale, the company is helping to establish new standards for how mental health support can be delivered efficiently across diverse populations. Their trajectory highlights the increasing convergence of consumer neurowellness, digital therapeutics, and enterprise health benefits as a defining force shaping the future of mental health care delivery.
More in Mental Health Tech
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 ยท Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 ยท Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 ยท Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 ยท Industry
Company details
Category
๐ Mental Health Tech
Location
Santa Monica, USA
Funding
Public ยท NASDAQ: MNMD (merged)
Website
headspace.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages โ